Alpharma Submits Embeda Abuse-Deterrent Morphine Capsule To FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Company files NDA slightly ahead of potential competitor Remoxy, in development by Pain Therapeutics.
You may also be interested in...
King Makes Play For Alpharma To Build Specialty Pain Franchise
Alpharma declines offer; King expresses hope for amicable resolution.
King Makes Play For Alpharma To Build Specialty Pain Franchise
Alpharma declines offer; King expresses hope for amicable resolution.
Alpharma Withdraws Embeda NDA
Resubmission is planned shortly; launch of the abuse-deterrent painkiller remains on track for first quarter 2009.